Izonsteride

Izonsteride
	File:Izonsteride-structure.png
Systematic (IUPAC) name
	(4aR,10bR)-8-[(4-ethyl-1,3-benzothiazol-2-yl)sulfanyl]-4,10b-dimethyl-1,4,4a,5,6,10b-hexahydrobenzo[f]quinolin-3(2H)-one
Clinical data
Routes of; administration	Oral
Legal status
Legal status	Uncontrolled;
Identifiers
CAS Number	176975-26-1
ATC code	none
PubChem	CID 172988
ChemSpider	151061
Chemical data
Formula	C24H26N2OS2
Molar mass	422.61 g/mol[[Script error: No such module "String".]]
	Script error: No such module "collapsible list".

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Izonsteride (LY-320,236) is a selective inhibitor of the 5α-redcutase, with dual effects on both the type I and type II isoforms of the enzyme.^[1] It was under development by Eli Lilly and Fujisawa for the treatment of benign prostatic hyperplasia (BPH) but was never marketed.^[2] Izonsteride may also be useful in the treatment of male pattern baldness (MPB).^[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />